Jefferies Financial Group... (JEF)
NYSE: JEF
· Real-Time Price · USD
53.85
1.65 (3.16%)
At close: Jun 16, 2025, 3:59 PM
54.32
0.87%
After-hours: Jun 16, 2025, 06:12 PM EDT
3.16% (1D)
| Bid | 53.5 |
| Market Cap | 11.11B |
| Revenue (ttm) | 10.3B |
| Net Income (ttm) | 707.35M |
| EPS (ttm) | 2.77 |
| PE Ratio (ttm) | 19.44 |
| Forward PE | 13.17 |
| Analyst | Hold |
| Ask | 54.32 |
| Volume | 1,044,939 |
| Avg. Volume (20D) | 1,903,284 |
| Open | 52.84 |
| Previous Close | 52.20 |
| Day's Range | 52.80 - 54.27 |
| 52-Week Range | 39.28 - 82.68 |
| Beta | 1.42 |
Analyst Forecast
According to 0 analyst ratings, the average rating for JEF stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Jefferies Financial Group Inc. is scheduled to release its earnings on Jun 30, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+2.72%
Shares of financial companies are trading higher, ...
Unlock content with
Pro Subscription
1 month ago
+7.41%
Shares of banks and financial services stocks are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A reduction in tariffs could alleviate macro uncertainty in the lending and deal environment.
5 days ago · https://www.defenseworld.net
19,564 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Purchased by Squarepoint Ops LLCSquarepoint Ops LLC bought a new stake in shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the...
